We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+20.36%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$26B
AUM Growth
-$12B
Cap. Flow
-$15.4B
Cap. Flow %
-59.14%
Top 10 Hldgs %
26.02%
Holding
8,334
New
1,055
Increased
1,987
Reduced
3,543
Closed
1,412

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$58M
2
ARM icon
Arm
ARM
+$57M
3
COIN icon
Coinbase
COIN
+$30.9M
4
MSFT icon
Microsoft
MSFT
+$30.2M
5
AMZN icon
Amazon
AMZN
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 3.22%
2 Financials 1.78%
3 Consumer Discretionary 1.72%
4 Healthcare 1.04%
5 Communication Services 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGC icon
5626
IGC Pharma
IGC
$26M
$14.9K ﹤0.01%
37,306
-23,153
-38% -$7.19K
XNET
5627
PUT
Xunlei
XNET
$339M
$14.9K ﹤0.01%
10,000
GNE icon
5628
Genie Energy
GNE
$370M
$14.9K ﹤0.01%
988
-358
-27% -$6.88K
CRIS icon
5629
Curis
CRIS
$9.63M
$14.9K ﹤0.01%
68
-251
-79% -$54K
XXII
5630
22nd Century Group
XXII
$1.35M
0
BIVI icon
5631
CALL
BioVie
BIVI
$11.5M
$14.9K ﹤0.01%
281
-72
-20% -$7.38K
PETS icon
5632
CALL
PetMed Express
PETS
$42.3M
$14.8K ﹤0.01%
3,100
-20,800
-87% -$121K
ZIMV
5633
PUT
DELISTED
ZimVie
ZIMV
$14.8K ﹤0.01%
900
-598,200
-100% -$10.7M
PRCT icon
5634
PUT
Procept Biorobotics
PRCT
$1.04B
$14.8K ﹤0.01%
300
-3,500
-92% -$167K
TMDX icon
5635
CALL
Transmedics
TMDX
$2.62B
$14.8K ﹤0.01%
200
-1,200
-86% -$98.9K
MNY icon
5636
MoneyHero
MNY
$41.9M
$14.8K ﹤0.01%
8,075
-31,347
-80% -$49.8K
GNL icon
5637
CALL
Global Net Lease
GNL
$1.84B
$14.8K ﹤0.01%
1,900
-1,800
-49% -$14.8K
BKKT icon
5638
PUT
Bakkt Inc
BKKT
$315M
$14.7K ﹤0.01%
1,280
-5,544
-81% -$149K
EE icon
5639
Excelerate Energy
EE
$1.25B
$14.6K ﹤0.01%
914
+624
+215% +$9.35K
ORMP icon
5640
PUT
Oramed Pharmaceuticals
ORMP
$167M
$14.6K ﹤0.01%
5,000
-14,100
-74% -$39.4K
NE icon
5641
PUT
Noble Corp
NE
$6.74B
$14.5K ﹤0.01%
300
+200
+200% +$9K
RXST icon
5642
RxSight
RXST
$250M
$14.5K ﹤0.01%
282
-531
-65% -$26.1K
PTCT icon
5643
CALL
PTC Therapeutics
PTCT
$5.67B
$14.5K ﹤0.01%
500
-4,900
-91% -$137K
LITS
5644
Lite Strategy Inc
LITS
$33M
$14.5K ﹤0.01%
3,634
-2,024
-36% -$9.18K
LEA icon
5645
CALL
Lear
LEA
$6.64B
$14.5K ﹤0.01%
+100
New +$13.7K
APRE icon
5646
Aprea Therapeutics
APRE
$7.99M
$14.4K ﹤0.01%
2,160
QUIK icon
5647
PUT
QuickLogic
QUIK
$236M
$14.4K ﹤0.01%
900
-1,200
-57% -$17.3K
CUZ icon
5648
CALL
Cousins Properties
CUZ
$5.25B
$14.4K ﹤0.01%
600
-1,400
-70% -$32.6K
NRDY icon
5649
Nerdy
NRDY
$104M
$14.4K ﹤0.01%
4,941
-6,378
-56% -$19.7K
SLAB icon
5650
PUT
Silicon Laboratories
SLAB
$7.17B
$14.4K ﹤0.01%
+100
New +$13.3K

Similar funds

Group One Trading's Q1 2024 Portfolio in Review

As of Q1 2024, Group One Trading held 8,334 positions worth $26B, down 32% from $38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Group One Trading withdrew a net $15.4B in Q1 2024, closing 1,412 positions and reducing 3,543 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 2.3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Group One Trading opened a new position in Arm worth $67.3M.

  • Group One Trading's largest Q1 2024 buy was Arm: 538,130 shares worth $67.3M.
  • Group One Trading added most to Alibaba in Q1 2024, an estimated $58M increase.
  • Group One Trading's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $61.3M.
  • Group One Trading fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $24.3M.
  • Group One Trading's ten largest holdings make up 26% of its $26B portfolio in Q1 2024.
  • Group One Trading opened 1,055 new positions and closed 1,412 in Q1 2024.
  • Group One Trading's portfolio value fell 32% quarter-over-quarter to $26B.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.